Ethicon GYNECARE TVT Products
→
Caldera Medical
Asset Acquisition · Cash (asset acquisition) · announced Mar 20, 2025
Announced
Mar 20, 2025
Closed
Mar 20, 2025
Economics
Undisclosed
Cash (asset acquisition)
Terms not publicly disclosed
Target
Ethicon GYNECARE TVT Products
Pelvic Health · Clinical / therapeutic
HQ Raritan, NJ · Founded 1998
GYNECARE TVT family of minimally invasive mesh slings for stress urinary incontinence — TVT, TVT Exact, TVT-O, TVT Abbrevo; gold standard with 20+ years of clinical data
- Business Wire — Caldera Medical press release (Mar 20, 2025)
- Ethicon/J&J product portfolio documentation
- Caldera Medical press release - product line acquisition, 2025
Acquirer
Caldera Medical
Healthcare
HQ Los Angeles, CA
Women's health medical device company — pelvic floor and stress urinary incontinence solutions; 23-year focus on women's health
Why this buyer
Curated copy from the verified dataset — not an 8-K LLM summary
TVT family (TVT, TVT Exact, TVT-O, TVT Abbrevo) is gold standard for minimally invasive stress urinary incontinence treatment — 20+ years clinical data; Caldera maintains same manufacturing and team
Evidence ladder
Secondary (press / IR)
Business Wire — Caldera Medical press release (Mar 20, 2025)
Limitations
- Single-source or weak corroboration — treat valuation and timing as directional.
- Deal value not disclosed in verified record; multiples and comparables exclude this transaction.
Valuation peers · Pelvic Health
Same sector, same deal type, announced within ±3 years, disclosed value within 0.25×–4× of this transaction. Ranked by evidence class, then same acquirer, until you sort.
Insufficient disclosed data
No verified Pelvic Health deals meet the peer rule: same deal type, announced within ±3 years, and a disclosed value inside 0.25×–4× of this transaction.
Other verified deals by Caldera Medical
Acquirer program history not already listed as a valuation peer or adjacency row.
No further verified deals
Other verified transactions by Caldera Medical are already listed above, or none are in the dataset.
Patient empowerment context
Patient empowerment baseline (HLTH 2022)
No curated mapping — Ethicon GYNECARE TVT Products (Pelvic Health). HLTH/Outcomes4Me 2022 baseline is Breast cancer care continuum (HLTH 2022). No curated mapping for this target in the verified crosswalk.
Research workspace (includes heuristic crosswalk) →Related verified workspaces
Lacuna is a curated public-source sample, not a census of women's-health M&A. Coverage varies by sector, geography, disclosure availability, and women's-health scope. Undisclosed transaction values are excluded from disclosed-value totals.
Curated verified dataset v11 · updated 2026-10-19 · 1 citations on this deal · Data compiled from public sources for educational visualization. Verify independently before any commercial use.